Stocktoria
Dr. Reddy's Laboratories Limited DRREDDY.NS
Dr. Reddy's Laboratories Limited statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (₹723.67); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Dr. Reddy's Laboratories Limited trades at about 23.3× earnings — above its 10-year norm (10-year range 17.5×–25.7×, median 18.5×).
Shaded band = 10-year range (17.5×–25.7×); dot = today's 23.3×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 52.8% | 58.5% | 58.6% | 56.7% |
| Operating margin | 14.9% | 22.1% | 23.4% | 24.0% |
| Net margin | 12.8% | 17.4% | 19.9% | 18.3% |
| FCF margin | 5.5% | 3.7% | 6.4% | 16.3% |
| Return on assets | 7.4% | 11.5% | 14.4% | 14.0% |
| Return on equity | 11.4% | 17.0% | 19.8% | 19.5% |
| Debt / equity | 0.03× | 0.01× | 0.01× | — |
| Current ratio | 1.80 | 1.92 | 2.58 | 2.38 |
Computed from company filings · IN · as of 2026-03-31. Figures in INR. Facts plus Stocktoria's own computed scores — not investment advice.